rs201551805
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000228.3(LAMB3):c.1705C>T(p.Arg569Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000496 in 1,613,840 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000228.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMB3 | NM_000228.3 | c.1705C>T | p.Arg569Ter | stop_gained | 14/23 | ENST00000356082.9 | NP_000219.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMB3 | ENST00000356082.9 | c.1705C>T | p.Arg569Ter | stop_gained | 14/23 | 1 | NM_000228.3 | ENSP00000348384 | P1 | |
LAMB3 | ENST00000367030.7 | c.1705C>T | p.Arg569Ter | stop_gained | 14/23 | 1 | ENSP00000355997 | P1 | ||
LAMB3 | ENST00000391911.5 | c.1705C>T | p.Arg569Ter | stop_gained | 13/22 | 1 | ENSP00000375778 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152234Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000521 AC: 13AN: 249462Hom.: 0 AF XY: 0.0000740 AC XY: 10AN XY: 135170
GnomAD4 exome AF: 0.0000479 AC: 70AN: 1461488Hom.: 0 Cov.: 36 AF XY: 0.0000481 AC XY: 35AN XY: 727080
GnomAD4 genome AF: 0.0000656 AC: 10AN: 152352Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74498
ClinVar
Submissions by phenotype
Junctional epidermolysis bullosa gravis of Herlitz Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 30, 2019 | Variant summary: LAMB3 c.1705C>T (p.Arg569X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 5.2e-05 in 249462 control chromosomes (gnomAD). This frequency is not significantly higher than expected for a pathogenic variant in LAMB3 causing Junctional Epidermolysis Bullosa (5.2e-05 vs 0.00093). c.1705C>T has been reported in the literature in individuals affected with Junctional Epidermolysis Bullosa (Kivirikko_1996, Fassihi_2004, Lucky_2018). Yenamandra_2017 reported the variant in homozygous state in a patient with Generalized Severe JEB and a poor prognosis, with strongly reduced staining for laminin-332 noted following immunofluorescence antigen mapping. These data indicate that the variant is very likely to be associated with disease. Two ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Likely pathogenic, criteria provided, single submitter | literature only | Counsyl | Apr 23, 2014 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 11, 2020 | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. - |
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 09, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 21, 2023 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 8824879, 29334134, 28087116, 15725250, 11023379, 12813757, 9160387, 33921969, 16473856, 32484238, 36287101) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | This sequence change creates a premature translational stop signal (p.Arg569*) in the LAMB3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMB3 are known to be pathogenic (PMID: 11023379, 16473856). This variant is present in population databases (rs201551805, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with junctional epidermolysis bullosa (PMID: 8824879, 11023379). ClinVar contains an entry for this variant (Variation ID: 188764). For these reasons, this variant has been classified as Pathogenic. - |
Junctional epidermolysis bullosa, non-Herlitz type Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Jan 03, 2022 | The variant has been reported at least twice as pathogenic/likely pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000188764, PMID:8824879). Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000052, PM2_M). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at